Special MRI to tell if growths in the uterus are cancerous
Part of Women’s health & pregnancy clinical trials.
This study uses a special type of MRI called diffusion-weighted imaging (DWI) to look at the endometrium (the lining of the uterus) and help tell the difference between benign and cancerous growths. The results will be compared to a biopsy to see how accurate the MRI is.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female.
- You have abnormal uterine bleeding or an ultrasound shows something unusual in your endometrium (the lining of the uterus).
- You have not had any previous treatment (surgery, hormone therapy, or radiation) for the current endometrial problem.
- You do not have a pacemaker or severe claustrophobia that would prevent you from having an MRI.
- You are not pregnant, and you do not have kidney problems that would make it unsafe to receive contrast dye if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses MRI scans and tissue samples to predict the molecular type and outlook of endometrial cancer, which may help guide treatment decisions.
This trial studies whether special scans (PET/MRI) can help predict how well endometrial cancer patients will do. You may be asked to get these scans before surgery, and your results may help classify your cancer risk.
This trial uses MRI scans to see if a computer can tell the difference between uterine sarcoma (a rare cancer) and fibroids (non-cancerous growths). If you've already been diagnosed with one of these and had an MRI before surgery, you may be able to help.
This study uses a special type of MRI called diffusion-weighted imaging to help diagnose breast cancer and check on it after treatment. It is for women who have a breast lump or whose breast cancer has returned after chemotherapy or radiation.
This study uses MRI imaging to look at pelvic masses and help tell the difference between benign (non-cancerous) and malignant (cancerous) conditions. It is designed for people referred for a prostate MRI or for endometriosis evaluation before surgery.
This study uses special MRI scans to improve how doctors tell the difference between benign uterine fibroids and rare uterine sarcomas. It may help avoid unnecessary surgeries or catch cancer earlier.
Hear when a new Endometrial Lesions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.